Amneal Pharmaceuticals of New York LLC
Amneal Pharmaceuticals is dedicated to making healthy possible through innovative medicines, accessible healthcare, and a commitment to sustainability. They operate globally, developing first-to-file and first-to-market complex medicines, and are actively involved in community and environmental initiatives. Their mission emphasizes collaboration, quality, and integrity to deliver value and improve lives.
Industries
Nr. of Employees
Very Large (1000+)
Amneal Pharmaceuticals of New York LLC
Bridgewater, New Jersey, United States, North America
Products
Broad portfolio of generic and specialty pharmaceuticals
Approximately 280+ marketed generic and specialty products covering a range of therapeutic areas and dosage forms for retail, institutional and international markets.
Autoinjector for acute migraine treatment (FDA-approved)
An FDA-approved autoinjector product for acute migraine/cluster headache treatment delivered via subcutaneous injection; includes regulatory-approved prescribing information and boxed warning elements in labeling.
Extended-release carbidopa/levodopa capsules for Parkinson's disease (commercial launch)
Extended-release oral capsule formulation for symptomatic treatment of Parkinson’s disease delivered as a commercial specialty product.
Naloxone HCl nasal spray (over-the-counter distribution)
Nasal-spray opioid overdose reversal product distributed through retail channels and deployed in public-health outreach and donation programs to increase access.
Broad portfolio of generic and specialty pharmaceuticals
Approximately 280+ marketed generic and specialty products covering a range of therapeutic areas and dosage forms for retail, institutional and international markets.
Autoinjector for acute migraine treatment (FDA-approved)
An FDA-approved autoinjector product for acute migraine/cluster headache treatment delivered via subcutaneous injection; includes regulatory-approved prescribing information and boxed warning elements in labeling.
Extended-release carbidopa/levodopa capsules for Parkinson's disease (commercial launch)
Extended-release oral capsule formulation for symptomatic treatment of Parkinson’s disease delivered as a commercial specialty product.
Naloxone HCl nasal spray (over-the-counter distribution)
Nasal-spray opioid overdose reversal product distributed through retail channels and deployed in public-health outreach and donation programs to increase access.
Services
Commercial manufacturing of generic and specialty medicines
Large-scale production and distribution services supporting a broad portfolio of generics and specialty pharmaceuticals for retail, institutional and international customers.
Drug-safety and pharmacovigilance services
Adverse event reporting, medical inquiry handling and product complaint management to support post-market safety surveillance.
Patient access and copay assistance programs
Programs and card-based mechanisms to reduce patient out-of-pocket costs for eligible commercially insured patients.
Product partnering and co-development
Collaborative arrangements to co-develop or license products and technologies for expanded market reach.
Commercial manufacturing of generic and specialty medicines
Large-scale production and distribution services supporting a broad portfolio of generics and specialty pharmaceuticals for retail, institutional and international customers.
Drug-safety and pharmacovigilance services
Adverse event reporting, medical inquiry handling and product complaint management to support post-market safety surveillance.
Patient access and copay assistance programs
Programs and card-based mechanisms to reduce patient out-of-pocket costs for eligible commercially insured patients.
Product partnering and co-development
Collaborative arrangements to co-develop or license products and technologies for expanded market reach.
Expertise Areas
- Generic drug development
- Specialty pharmaceutical development
- Drug delivery technologies
- Biosimilars development
Key Technologies
- Topical formulation
- Transdermal patch formulation
- Transmucosal delivery
- Inhalation formulation and device delivery